Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

New phase I/II data on vector-based malaria vaccines

Dec. 14, 2011

Hand, foot and mouth disease vaccine is safe and immunogenic

Dec. 13, 2011

Lilly describes antitumor effects of dual cyclin-dependent kinase inhibitor

Dec. 13, 2011

Boehringer Ingelheim discloses preclinical data on MAb targeting insulin-like growth factor I and II

Dec. 13, 2011

Mutant-selective inhibitor of epidermal growth factor receptor assessed in NSCLC

Dec. 13, 2011

Promising in vivo data presented on BI-853520

Dec. 13, 2011

S-44563 assessed in vivo in models of uveal melanoma

Dec. 13, 2011

ENGAGE-501 study evaluates entinostat in Hodgkin's lymphoma

Dec. 12, 2011

OZ-439 reduces parasitemia in proof-of-concept study

Dec. 12, 2011

Merz Pharmaceuticals NME shows antidyskinetic efficacy

Dec. 12, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 11, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026